Knock out of CD123 or CLL-1 By CRISPR-Cas9 Editing from Human Hematopoietic Stem Cell Transplants...

[PDF] hosct.org

Adoptive cellular therapy in acute myeloid leukemia: Current scope and challenges

S Arora, P Asawa, A Ramakrishnan, C Bachier… - … /Oncology and Stem Cell …, 2022 - hosct.org
Adoptive cellular therapies have revolutionized the management of hematologic
malignancies, particularly lymphoma and multiple myeloma. These novel therapies targeting …
相关文章 所有 3 个版本